IMPACT OF TRADE AND TRIPS ON AFFORDABILITY OF MEDICINE IN TANZANIAAbstract
To meet healthcare demands and costs, Tanzania depends largely on imports and financial aid from foreign countries. Current research analyses the impact of market competition on the cost and availability of medicine in Tanzania. Product approvals granted by Tanzanian drug regulatory authority were analyzed on the basis of exporting countries, molecules and therapeutic categories. The market competition among various countries was analyzed using UN trade statistics database ‘Comtrade’. Our analysis revealed that India offers large number of competing vendors per molecule and has the highest average share in the product approvals granted in all major therapeutic categories. The analysis also reveals that most of the currently used second line therapy molecules that are essential for Tanzania are protected by patents and the country needs to consider utilization of TRIPS flexibilities to improve accessibility and affordability of medicine.
Srikanth Ineedi , Deepak Kumar Jena*, Poduri Balaram , Swaroopa Bobba
Manager, International Business Development, UAS Laboratories, Inc, 9953 Valley View Road, Eden Prairie, MN 55344
03 May, 2012
07 June, 2012
19 August, 2012
01 September, 2012